Doxacurium vs. Pancuronium

Crit Care Med. 1996 Feb;24(2):366-7. doi: 10.1097/00003246-199602000-00036.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Cost-Benefit Analysis
  • Drug Costs
  • Humans
  • Intensive Care Units
  • Isoquinolines / economics*
  • Neuromuscular Nondepolarizing Agents / economics*
  • Pancuronium / economics*

Substances

  • Isoquinolines
  • Neuromuscular Nondepolarizing Agents
  • Pancuronium
  • doxacurium